- Home
- QUIK vs ARMP Comparison
QUIK vs ARMP Comparison
Compare QUIK & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QUIK
- ARMP
- Stock Information
- Founded
- QUIK 1988
- ARMP N/A
- Country
- QUIK United States
- ARMP United States
- Employees
- QUIK N/A
- ARMP N/A
- Industry
- QUIK Semiconductors
- ARMP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- QUIK Technology
- ARMP Health Care
- Exchange
- QUIK Nasdaq
- ARMP Nasdaq
- Market Cap
- QUIK 100.1M
- ARMP 92.4M
- IPO Year
- QUIK 1997
- ARMP N/A
- Fundamental
- Price
- QUIK $5.62
- ARMP $2.94
- Analyst Decision
- QUIK Strong Buy
- ARMP Strong Buy
- Analyst Count
- QUIK 3
- ARMP 1
- Target Price
- QUIK $10.87
- ARMP $9.00
- AVG Volume (30 Days)
- QUIK 179.8K
- ARMP 12.7K
- Earning Date
- QUIK 11-10-2025
- ARMP 11-12-2025
- Dividend Yield
- QUIK N/A
- ARMP N/A
- EPS Growth
- QUIK N/A
- ARMP N/A
- EPS
- QUIK N/A
- ARMP N/A
- Revenue
- QUIK $18,359,000.00
- ARMP $6,868,000.00
- Revenue This Year
- QUIK $11.58
- ARMP $8.43
- Revenue Next Year
- QUIK $22.73
- ARMP N/A
- P/E Ratio
- QUIK N/A
- ARMP N/A
- Revenue Growth
- QUIK N/A
- ARMP 84.67
- 52 Week Low
- QUIK $4.26
- ARMP $0.90
- 52 Week High
- QUIK $13.36
- ARMP $3.14
- Technical
- Relative Strength Index (RSI)
- QUIK 52.32
- ARMP 61.74
- Support Level
- QUIK $5.00
- ARMP $2.79
- Resistance Level
- QUIK $5.56
- ARMP $3.03
- Average True Range (ATR)
- QUIK 0.24
- ARMP 0.15
- MACD
- QUIK 0.06
- ARMP 0.02
- Stochastic Oscillator
- QUIK 91.11
- ARMP 72.97
About QUIK QuickLogic Corporation
QuickLogic Corp provides programmable silicon and software platforms to enable its customers to develop custom hardware products in a fast time-to-market and cost-effective way. QuickLogic is a fabless semiconductor company with a product range: embedded FPGA (eFPGA) intellectual property (IP), low power, multi-core semiconductor system-on-chips (SoCs), discrete FPGAs, and AI software. The full range of platforms, software tools, and eFPGA IP enables the practical and efficient adoption of AI, voice, and sensor processing across Aerospace, and Defense, Consumer/Industrial IoT, and Consumer Electronics markets.
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.